These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17180762)

  • 1. [The Tenovofir trial in Cameroun. Analysis of the controversial positions and proposal for an ethical alternative].
    Munday F; Lubangi G; Mukandu F; Leyens S
    Sante; 2006; 16(2):131-3. PubMed ID: 17180762
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of tenofovir in the prevention of HIV infections.
    De Clercq E
    AIDS; 2006 Oct; 20(15):1990-1. PubMed ID: 16988528
    [No Abstract]   [Full Text] [Related]  

  • 3. Stakeholder consultation to address issues related to tenofovir prophylactic research.
    Halima Y; Collins C
    IAPAC Mon; 2005 Jun; 11(6):166-9. PubMed ID: 16276586
    [No Abstract]   [Full Text] [Related]  

  • 4. Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm.
    Roehr B
    BMJ; 2011 Jul; 343():d4540. PubMed ID: 21765115
    [No Abstract]   [Full Text] [Related]  

  • 5. Five-year data out on Viread.
    AIDS Patient Care STDS; 2006 Dec; 20(12):887-8. PubMed ID: 17219618
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 7. Moving toward assured access to treatment in microbicide trials. Global Campaign for Microbicides.
    Forbes A
    PLoS Med; 2006 Jul; 3(7):e153. PubMed ID: 16805648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Parienti JJ
    J Antimicrob Chemother; 2009 May; 63(5):1080; author reply 1080-1. PubMed ID: 19158108
    [No Abstract]   [Full Text] [Related]  

  • 9. Retrovirus meeting. Novel attacks on HIV move closer to reality.
    Cohen J
    Science; 2006 Feb; 311(5763):943. PubMed ID: 16484468
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
    Redfield RR; Morrow JS
    Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
    Taéron C
    Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. Merck integrase inhibitor.
    TreatmentUpdate; 2006; 18(4):3-4. PubMed ID: 17205652
    [No Abstract]   [Full Text] [Related]  

  • 13. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases.
    Sabbatini F; Prati F; Borghi V; Bedini A; Esposito R; Mussini C
    Infection; 2007 Dec; 35(6):474-6. PubMed ID: 18034206
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.
    Tamalet C; Tomei C; Henry M; Solas C; Villacian J; Colson P
    AIDS; 2007 Nov; 21(18):2551-2. PubMed ID: 18025898
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprophylaxis of HIV infection: moving forward with caution.
    Grant RM; Wainberg MA
    J Infect Dis; 2006 Oct; 194(7):874-6. PubMed ID: 16960773
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
    [No Abstract]   [Full Text] [Related]  

  • 18. Tenofovir: what have over 1 million years of patient experience taught us?
    Pozniak A
    Int J Clin Pract; 2008 Aug; 62(8):1285-93. PubMed ID: 18705824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.
    Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; MacQueen KM
    Sex Transm Dis; 2008 Dec; 35(12):1002-8. PubMed ID: 19051397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV agents. No interaction between tenofovir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17216838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.